166 related articles for article (PubMed ID: 35973341)
1. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
[TBL] [Abstract][Full Text] [Related]
2. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
Khair S; Eastwood CA; Lu M; Jackson J
Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
[TBL] [Abstract][Full Text] [Related]
3. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
[TBL] [Abstract][Full Text] [Related]
4. Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island.
Zang X; Bessey SE; Krieger MS; Hallowell BD; Koziol JA; Nolen S; Behrends CN; Murphy SM; Walley AY; Linas BP; Schackman BR; Marshall BDL
JAMA Netw Open; 2022 Nov; 5(11):e2241174. PubMed ID: 36350649
[TBL] [Abstract][Full Text] [Related]
5. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
[TBL] [Abstract][Full Text] [Related]
7. Can Emergency Department, Hospital Discharge, and Death Data Be Used to Monitor Burden of Drug Overdose in Rhode Island?
Jiang Y; McDonald JV; Koziol J; McCormick M; Viner-Brown S; Alexander-Scott N
J Public Health Manag Pract; 2017; 23(5):499-506. PubMed ID: 28009694
[TBL] [Abstract][Full Text] [Related]
8. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.
Irwin A; Jozaghi E; Weir BW; Allen ST; Lindsay A; Sherman SG
Harm Reduct J; 2017 May; 14(1):29. PubMed ID: 28532488
[TBL] [Abstract][Full Text] [Related]
9. Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths.
Tse WC; Scott N; Dietze P; Nielsen S
J Subst Abuse Treat; 2022 Dec; 143():108871. PubMed ID: 36182753
[TBL] [Abstract][Full Text] [Related]
10. Using Timely Overdose Data to Address a Spike in Nonfatal Overdoses and Inform a Coordinated Community-Level Response in Rhode Island, 2019.
Lasher L; Hallowell BD; Chambers LC; Koziol J; McDonald J; Elmaleh R; Karim S; Viner-Brown S
Public Health Rep; 2021; 136(1_suppl):24S-30S. PubMed ID: 34726976
[TBL] [Abstract][Full Text] [Related]
11. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs.
Adams JW; Savinkina A; Fox A; Behrends CN; Madushani RWMA; Wang J; Chatterjee A; Walley AY; Barocas JA; Linas BP
Addiction; 2022 Oct; 117(10):2635-2648. PubMed ID: 35315148
[TBL] [Abstract][Full Text] [Related]
12. Prior Emergency Medical Services Utilization Among People Who Had an Accidental Opioid-Involved Fatal Drug Overdose-Rhode Island, 2018-2020.
Duan K; Chambers LC; Basta M; Scagos RP; Roberts-Santana C; Hallowell BD
Public Health Rep; 2024; 139(1):48-53. PubMed ID: 36891978
[TBL] [Abstract][Full Text] [Related]
13. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
[TBL] [Abstract][Full Text] [Related]
14. Opening Canada's first Health Canada-approved supervised consumption sites.
Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
[TBL] [Abstract][Full Text] [Related]
15. Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study.
Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S
Int J Drug Policy; 2022 Dec; 110():103894. PubMed ID: 36308892
[TBL] [Abstract][Full Text] [Related]
16. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
Wallace B; Pagan F; Pauly BB
Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
[TBL] [Abstract][Full Text] [Related]
17. Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada.
Scheim AI; Bouck Z; Tookey P; Hopkins S; Sniderman R; McLean E; Garber G; Baral S; Rourke SB; Werb D
Int J Drug Policy; 2021 Jan; 87():102993. PubMed ID: 33160158
[TBL] [Abstract][Full Text] [Related]
18. Examination of the Accuracy of Existing Overdose Surveillance Systems.
Griffith J; Chambers LC; Hallowell BD; Gaipo A; Mailloux C; Baird J; Beaudoin FL; Samuels EA
JAMA Netw Open; 2023 Jun; 6(6):e2320789. PubMed ID: 37378980
[TBL] [Abstract][Full Text] [Related]
19. Anticipated use of a supervised drug consumption site among syringe services program clients in King County, Washington: Assessing the role of opioid overdose and injection behavior.
Klein KS; Glick SN; Mauro PM
Drug Alcohol Depend; 2020 Aug; 213():108121. PubMed ID: 32585421
[TBL] [Abstract][Full Text] [Related]
20. Mobile supervised consumption services in Rural British Columbia: lessons learned.
Mema SC; Frosst G; Bridgeman J; Drake H; Dolman C; Lappalainen L; Corneil T
Harm Reduct J; 2019 Jan; 16(1):4. PubMed ID: 30634986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
